Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
European Journal of Pharmacology|July 11, 2019
Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's diseaseDésirée H Veening-Griffioen, Guilherme S Ferreira, Peter J K van Meer, et al.
ALTEX|June 28, 2020
Tradition, not science, is the basis of animal model selection in translational and applied researchDésirée H Veening-Griffioen, Guilherme S Ferreira, Wouter P C Boon, et al.
Plos One|June 14, 2019
A standardised framework to identify optimal animal models for efficacy assessment in drug developmentGuilherme S Ferreira, Désirée H Veening-Griffioen, Wouter P C Boon, et al.
The Gerontologist|December 6, 2021
Toward Responsible Artificial Intelligence in Long-Term Care: A Scoping Review on Practical ApproachesDirk R M Lukkien, Henk Herman Nap, Hendrik P Buimer, et al.
The Journal of Clinical Endocrinology and Metabolism|November 19, 2010
Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolismN J van der Zijl, G H Goossens, C C M Moors, et al.
Malaria Journal|September 6, 2023
Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong SubregionFreek de Haan, Chanaki Amaratunga, Van Anh Cao Thi, et al.
JMIR Nursing|July 25, 2024
AI-Assisted Decision-Making in Long-Term Care: Qualitative Study on Prerequisites for Responsible InnovationDirk R M Lukkien, Nathalie E Stolwijk, Sima Ipakchian Askari, et al.
JMIR Human Factors|July 31, 2024
Making Co-Design More Responsible: Case Study on the Development of an AI-Based Decision Support System in Dementia CareDirk R M Lukkien, Sima Ipakchian Askari, Nathalie E Stolwijk, et al.
Plos One|July 7, 2012
Valsartan improves adipose tissue function in humans with impaired glucose metabolism: a randomized placebo-controlled double-blind trialGijs H Goossens, Chantalle C M Moors, Nynke J van der Zijl, et al.
Translational Psychiatry|March 1, 2023
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugsGuilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, et al.
Pageof 8